A 5-year-old previously healthy child is taken from his day care to the pediatrician because his mother is concerned that the child has been fussy for the past few days and now has a rash on his face and torso . The mother also says the boy told her his head hu, and she thinks he may have a low-grade fever. On examination the child is afebrile and not ill-appearing. He has a rash extending over his entire body except for the palms and soles. The infectious agent causing this disease can lead to what complication in immunocompromised hosts?
A 5-year-old previously healthy child is taken from his day care to the pediatrician because his mother is concerned that the child has been fussy for the past few days and now has a rash on his face and torso . The mother also says the boy told her his head hu, and she thinks he may have a low-grade fever. On examination the child is afebrile and not ill-appearing. He has a rash extending over his entire body except for the palms and soles. The infectious agent causing this disease can lead to what complication in immunocompromised hosts?
💡 Explanation
## **Core Concept**
The question describes a child presenting with a rash that spares the palms and soles, accompanied by symptoms suggestive of a viral illness. The clinical presentation is suggestive of **varicella** (chickenpox), caused by the **varicella-zoster virus (VZV)**. A significant concern with VZV infection is its potential to cause severe complications in immunocompromised individuals.
## **Why the Correct Answer is Right**
In immunocompromised hosts, the varicella-zoster virus can lead to a serious complication known as **disseminated herpes zoster** or **varicella**. This condition occurs when the virus reactivates from its latent phase in the dorsal root ganglia and disseminates widely, often affecting multiple dermatomes and potentially involving internal organs. This can lead to severe illness, including **pneumonia**, **encephalitis**, and **multi-organ failure**, which are particularly concerning in immunocompromised patients due to their inability to mount an effective immune response.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, incorrect options might include other viral complications not directly related to VZV in immunocompromised hosts.
- **Option B:** Similarly, without the specific content of Option B, it's challenging to address directly, but one might expect it to relate to a different viral or bacterial complication.
- **Option C:** Again, lacking the specific details of Option C, one can infer that it might relate to a complication not specifically associated with VZV in immunocompromised patients.
## **Clinical Pearl / High-Yield Fact**
A critical clinical pearl is that **immunocompromised patients** are at increased risk of **VZV reactivation** leading to herpes zoster, and this can disseminate. These patients may benefit from **prophylactic antiviral therapy** or **vaccination** strategies to mitigate this risk. The **acyclovir** and other antiviral drugs are used to treat VZV infections, especially in high-risk populations.
## **Correct Answer:** D. Disseminated herpes zoster/varicella.
✓ Correct Answer: A. Aplastic anemia
📤 Share this MCQ
Share Card Preview
👆 1080x1080 square card — fills the full width in WhatsApp and Telegram